Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: Relevant clinical aspects

Annals of Oncology

Volumn 12, Issue SUPPLE. 2, 2001, Pages

  Doga, M ^a   Bonadonna, S ^a   Burattin, A ^a   Giustina, A ^a  

^a SPEDALI CIVILI   (Italy)

Author keywords

Acromegaly; Carcinoid tumors; GHRH; GHRH analogs; Tumors

Indexed keywords

ANGIOPEPTIN; CELL SURFACE RECEPTOR; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR ANTAGONIST; HORMONE ANTAGONIST; MESSENGER RNA; MZ 471; MZ 5 156; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG;

ACROMEGALY; ADRENAL CORTEX ADENOMA; AMINO ACID SUBSTITUTION; BINDING AFFINITY; BREAST CANCER; CANCER CELL CULTURE; CANCER SURGERY; CANCER THERAPY; CARCINOGENESIS; CARCINOID; CARCINOID SYNDROME; CELL STIMULATION; CHORISTOMA; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIGESTIVE SYSTEM; ECTOPIC HORMONE PRODUCTION; ENDOMETRIUM CANCER; EXTRACTION; GANGLIONEUROMA; GLIOMA; GROWTH HORMONE RELEASE; HAMARTOMA; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE STRUCTURE; HORMONE SYNTHESIS; HUMAN; HYPOPHYSIS; HYPOPHYSIS ADENOMA; HYPOTHALAMUS; HYPOTHALAMUS TUMOR; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LUNG SMALL CELL CANCER; NERVE CELL; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; OVARY; OVARY CANCER; PANCREAS; PANCREAS TUMOR; PHEOCHROMOCYTOMA; PHYSIOLOGY; PORTAL VEIN; PRIORITY JOURNAL; RADIODIAGNOSIS; RECEPTOR BINDING; RETROSPECTIVE STUDY; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL; SYSTEMIC CIRCULATION; TESTIS;

EID: 0035170491     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/12.suppl_2.s89     Document Type: Review

References (54)

1. Acromegaly with somatotroph hyperplasia: Successful treatment by resection of a pancreatic tumor secreting a growth hormone (GH) releasing factor (GRF)
2. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly
3. Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone-releasing activity
4. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumor
5. Immunohistochemical detection of growth hormone-releasing factor in brain
6. Characterization of rat hypothalamic growth hormone-releasing factor
7. Stimulation of adenosine3,5-monophosphate production by growth hormone-releasing factors and its inhibition by somatostatin in anterior pituitary cells in vitro
8. Molecular cloning and expression of a pituitary receptor for growth hormone-releasing hormone
9. Growth hormone releasing hormone 1-40-OH (GHRH) is a prolacting releasing factor
10. Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor
11. Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells
12. Growth hormone synthesis and release in vitro: Effects of parially purified ovine hypothalamic extract
13. Independent effects of growth hormone-releasing factor on growth hormone release and gene transcription
14. Basal and dibutyryl cyclic AMP-stimulated release of a newly synthesized and stored growth hormone from perfused rat pituitaries
15. Growth hormone: Independent release of big and small forms from rat pituitary in vitro
16. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human
17. Effects of a growth hormone-releasing factor in man
18. Effects of growth hormone-releasing factor on growth hormone secretion in acromegaly
19. Effect of Galanin on the growth hormone (GH) to GH-releasing hormone in acromegaly
20. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of growth hormone-releasing factor (1-40). Evidence for intermittent somatostatin secretion
21. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men a GH-deficient boy
22. Growth Hormone-releasing hormone
23. A case for hypothalamic acromegaly: A clinopathological study of six patients with hypothalamic ganglyocitomas producing growth hormone releasing factor
24. Gigantism due to pituitary mammosomatotroph hyperplasia
25. Distribution of immunoreactive growth hormone-releasing hormone in the human brain and intestine and its production by tumors
26. Multiple forms of immunoreactive growth hormone-releasing hormone in human plasma, hypothalamus, and tumor tissue
27. Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: Plasma GRH levels in 177 acromegalic patients
28. Acromegaly caused by pulmonary carcinoid tumors
29. Partial purification and characterization of a peptide with GH releasing activity from extrapituitary tumors in agents with acromegaly
30. Ectopic secretion of a growth hormone-secreting factor. Report of a case of acromegaly with bronchial carcinoid tumor
31. Acromegalic expression clinique de la prodution de factures de liberation de l'hormone de croissance (GRF) par un tumeur pancreatique
32. Ectopic acromegaly
33. Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor: Successful treatment with lung-acting somatostatin analogue SMS 201-995
34. Serum growth hormone in patients with carcinoid tumors: Basal levels and response to glucose and thyrotrophin releasing hormone
35. Immunocytochemical demonstration of growth hormone-releasing factor in gastrointestinal and pancreatic endocrine tumors
36. Metabolic clearance and plasma dissappearance rates of human pancreatic tumor growth hormone releasing factor in man
37. Pharmacological aspects of the treatment of acromegaly
38. Acromegaly with 'normal' serum growth hormone levels: Clinical features, diagnosis and results of transsphenoidal microsurgery
39. Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor
40. Expression of growth hormone releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers
41. Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice and inhibit the expression of mRNA for IGF-I in tumours
42. Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastomas in nude mice
43. Inhibition of growth, production of insuline-like growth factor II (IGF-II), and the expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro
44. Antagonistic analogs of growth hormone-releasing hormone (GHRH): Endocrine and oncological studies
45. Synthesis and in vitro evaluation of new potent antagonists of growth hormone-releasing hormone (GHRH)
46. Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities
47. Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone
48. Expression of insulin like growth factor (IGF) and IGF-binding protein genes in human lung tumor cell lines
49. Antagonist analogs of Growth hormone-releasing hormone: New potential antitumor agents
50. Growth hormone-releasing hormone (GHRH) antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma
51. Growth hormone releasing antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors
52. Nocturnal growth hormone secretion is eliminated by infusion of Gh-releasing-hormone antagonist
53. Suppression of growth hormone (GH) hypersecretion due to ectopic GH-releasing hormone (GHRH) by a selective GHRH antagonist
54. Loss of sst2 somatostatin recepor gene expression in human pancreatic and colorectal cancer